Cargando…

Application of aptamer functionalized nanomaterials in targeting therapeutics of typical tumors

Cancer is a major cause of human death all over the world. Traditional cancer treatments include surgery, radiotherapy, chemotherapy, immunotherapy, and hormone therapy. Although these conventional treatment methods improve the overall survival rate, there are some problems, such as easy recurrence,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Xiujuan, He, Zhenqiang, Ge, Weiying, Zhao, Zhenhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978196/
https://www.ncbi.nlm.nih.gov/pubmed/36873354
http://dx.doi.org/10.3389/fbioe.2023.1092901
_version_ 1784899465214164992
author Yin, Xiujuan
He, Zhenqiang
Ge, Weiying
Zhao, Zhenhua
author_facet Yin, Xiujuan
He, Zhenqiang
Ge, Weiying
Zhao, Zhenhua
author_sort Yin, Xiujuan
collection PubMed
description Cancer is a major cause of human death all over the world. Traditional cancer treatments include surgery, radiotherapy, chemotherapy, immunotherapy, and hormone therapy. Although these conventional treatment methods improve the overall survival rate, there are some problems, such as easy recurrence, poor treatment, and great side effects. Targeted therapy of tumors is a hot research topic at present. Nanomaterials are essential carriers of targeted drug delivery, and nucleic acid aptamers have become one of the most important targets for targeted tumor therapy because of their high stability, high affinity, and high selectivity. At present, aptamer-functionalized nanomaterials (AFNs), which combine the unique selective recognition characteristics of aptamers with the high-loading performance of nanomaterials, have been widely studied in the field of targeted tumor therapy. Based on the reported application of AFNs in the biomedical field, we introduce the characteristics of aptamer and nanomaterials, and the advantages of AFNs first. Then introduce the conventional treatment methods for glioma, oral cancer, lung cancer, breast cancer, liver cancer, colon cancer, pancreatic cancer, ovarian cancer, and prostate cancer, and the application of AFNs in targeted therapy of these tumors. Finally, we discuss the progress and challenges of AFNs in this field.
format Online
Article
Text
id pubmed-9978196
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99781962023-03-03 Application of aptamer functionalized nanomaterials in targeting therapeutics of typical tumors Yin, Xiujuan He, Zhenqiang Ge, Weiying Zhao, Zhenhua Front Bioeng Biotechnol Bioengineering and Biotechnology Cancer is a major cause of human death all over the world. Traditional cancer treatments include surgery, radiotherapy, chemotherapy, immunotherapy, and hormone therapy. Although these conventional treatment methods improve the overall survival rate, there are some problems, such as easy recurrence, poor treatment, and great side effects. Targeted therapy of tumors is a hot research topic at present. Nanomaterials are essential carriers of targeted drug delivery, and nucleic acid aptamers have become one of the most important targets for targeted tumor therapy because of their high stability, high affinity, and high selectivity. At present, aptamer-functionalized nanomaterials (AFNs), which combine the unique selective recognition characteristics of aptamers with the high-loading performance of nanomaterials, have been widely studied in the field of targeted tumor therapy. Based on the reported application of AFNs in the biomedical field, we introduce the characteristics of aptamer and nanomaterials, and the advantages of AFNs first. Then introduce the conventional treatment methods for glioma, oral cancer, lung cancer, breast cancer, liver cancer, colon cancer, pancreatic cancer, ovarian cancer, and prostate cancer, and the application of AFNs in targeted therapy of these tumors. Finally, we discuss the progress and challenges of AFNs in this field. Frontiers Media S.A. 2023-02-16 /pmc/articles/PMC9978196/ /pubmed/36873354 http://dx.doi.org/10.3389/fbioe.2023.1092901 Text en Copyright © 2023 Yin, He, Ge and Zhao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Yin, Xiujuan
He, Zhenqiang
Ge, Weiying
Zhao, Zhenhua
Application of aptamer functionalized nanomaterials in targeting therapeutics of typical tumors
title Application of aptamer functionalized nanomaterials in targeting therapeutics of typical tumors
title_full Application of aptamer functionalized nanomaterials in targeting therapeutics of typical tumors
title_fullStr Application of aptamer functionalized nanomaterials in targeting therapeutics of typical tumors
title_full_unstemmed Application of aptamer functionalized nanomaterials in targeting therapeutics of typical tumors
title_short Application of aptamer functionalized nanomaterials in targeting therapeutics of typical tumors
title_sort application of aptamer functionalized nanomaterials in targeting therapeutics of typical tumors
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978196/
https://www.ncbi.nlm.nih.gov/pubmed/36873354
http://dx.doi.org/10.3389/fbioe.2023.1092901
work_keys_str_mv AT yinxiujuan applicationofaptamerfunctionalizednanomaterialsintargetingtherapeuticsoftypicaltumors
AT hezhenqiang applicationofaptamerfunctionalizednanomaterialsintargetingtherapeuticsoftypicaltumors
AT geweiying applicationofaptamerfunctionalizednanomaterialsintargetingtherapeuticsoftypicaltumors
AT zhaozhenhua applicationofaptamerfunctionalizednanomaterialsintargetingtherapeuticsoftypicaltumors